Since 1993, three Indigenous children in north Queensland have died of fulm
inant hepatitis A. Even if the children had been able to undergo liver tran
splantation, prolonged immunosuppressant therapy and the likelihood of oppo
rtunistic infections would inevitably have jeopardised any chance of long-t
erm survival. As hepatitis A has become a leading infectious cause of death
in young Indigenous children in north Queensland, hepatitis A vaccine has
recently been introduced into the vaccination schedule for these children.